• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环孢素 A(CsA)药代动力学和药效学分析,以找到最佳的单点监测时间,用于调整同种异体造血干细胞移植中每日两次 3 小时静脉输注的 CsA 剂量。

Pharmacokinetic and pharmacodynamic analysis of cyclosporine A (CsA) to find the best single time point for the monitoring and adjusting of CsA dose using twice-daily 3-h intravenous infusions in allogeneic hematopoietic stem cell transplantation.

机构信息

Division of Bone Marrow Transplantation, Niigata University Medical and Dental Hospital, Asahimachi-dori 1-754, Chuoku, Niigata, Japan.

出版信息

Int J Hematol. 2010 Jul;92(1):144-51. doi: 10.1007/s12185-010-0610-0. Epub 2010 Jun 9.

DOI:10.1007/s12185-010-0610-0
PMID:20533008
Abstract

Pharmacological study is predictably effective in establishing an optimal monitoring strategy for the usage of cyclosporine A (CsA) to prevent graft-versus-host disease (GVHD) in allogeneic hematopoietic stem cell transplantation recipients. Pharmacokinetic profiling of 33 recipients administered CsA twice daily by 3-h intravenous infusion revealed that levels peaked 2-3 h after the start of infusion, and an exponential decline of CsA concentrations after the termination of infusion was observed. The correlation between the area under the curve (AUC(0-12)) and CsA concentration at various time points after infusion revealed that C (2) and C (3) correlated best with AUC(0-12) (r (2) = 0.725), while the trough concentration correlated poorly. Ex vivo T cell stimulation followed by intracellular cytokine detection with flow cytometry revealed that the capacity of T cells to produce cytokines upon stimulation was inversely proportional to the CsA concentration, and reached a minimum at about 700 ng/mL with a marginal decrease above this concentration. Extrapolation using the regression equations of this study and the data from our retrospective study leads to the assumption that the dose adjustment of CsA based on maintaining the C (3) concentration above 800 ng/mL may effectively prevent acute GVHD. To confirm this assumption, a prospective clinical study is required.

摘要

在预测性药物研究中,通过建立环孢素 A(CsA)的最佳监测策略,可有效预防异基因造血干细胞移植受者移植物抗宿主病(GVHD)。对 33 例每日两次静脉输注 3 小时 CsA 的受者进行药代动力学分析,结果显示输注开始后 2-3 小时达到峰值,输注结束后 CsA 浓度呈指数下降。输注后各时间点的 AUC(0-12)与 CsA 浓度之间的相关性表明,C(2)和 C(3)与 AUC(0-12)相关性最好(r(2)=0.725),而谷浓度相关性较差。体外 T 细胞刺激后,通过流式细胞术检测细胞内细胞因子,结果表明 T 细胞产生细胞因子的能力与 CsA 浓度呈反比,当 CsA 浓度约为 700ng/ml 时,其能力达到最低水平,在此浓度以上则略有下降。通过使用本研究的回归方程和我们回顾性研究的数据进行外推,假设基于维持 C(3)浓度高于 800ng/ml 来调整 CsA 剂量,可能有效地预防急性 GVHD。为了证实这一假设,需要进行前瞻性临床研究。

相似文献

1
Pharmacokinetic and pharmacodynamic analysis of cyclosporine A (CsA) to find the best single time point for the monitoring and adjusting of CsA dose using twice-daily 3-h intravenous infusions in allogeneic hematopoietic stem cell transplantation.环孢素 A(CsA)药代动力学和药效学分析,以找到最佳的单点监测时间,用于调整同种异体造血干细胞移植中每日两次 3 小时静脉输注的 CsA 剂量。
Int J Hematol. 2010 Jul;92(1):144-51. doi: 10.1007/s12185-010-0610-0. Epub 2010 Jun 9.
2
Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy.环孢素在异基因造血干细胞移植中的群体药代动力学:重点关注有限采样策略。
Br J Clin Pharmacol. 2012 Apr;73(4):553-63. doi: 10.1111/j.1365-2125.2011.04116.x.
3
Pharmacokinetics of cyclosporine A at a high-peak concentration of twice-daily infusion and oral administration in allogeneic haematopoietic stem cell transplantation.环孢素 A 在异基因造血干细胞移植中两次每日输注和口服高峰浓度时的药代动力学。
J Clin Pharm Ther. 2011 Aug;36(4):518-24. doi: 10.1111/j.1365-2710.2010.01199.x. Epub 2010 Nov 25.
4
Risk factors for acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: retrospective analysis of 73 patients who received cyclosporin A.异基因造血干细胞移植后急性移植物抗宿主病的危险因素:对73例接受环孢素A治疗患者的回顾性分析
Bone Marrow Transplant. 2007 Nov;40(9):875-80. doi: 10.1038/sj.bmt.1705834. Epub 2007 Aug 27.
5
Pharmacokinetics of CsA during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation.他克莫司在异基因造血干细胞移植后从连续静脉输注转换为口服给药时的药代动力学。
Bone Marrow Transplant. 2010 Jun;45(6):1088-94. doi: 10.1038/bmt.2009.316. Epub 2009 Nov 9.
6
Pharmacokinetics of cyclosporine a conversion from twice-daily infusion to oral administration in allogeneic hematopoietic stem cell transplantation.环孢素A在异基因造血干细胞移植中从每日两次静脉输注转换为口服给药的药代动力学
Am J Ther. 2014 Sep-Oct;21(5):377-84. doi: 10.1097/MJT.0b013e318256ed25.
7
Decreased incidence of acute graft-versus-host disease by continuous infusion of cyclosporine with a higher target blood level.通过持续输注环孢素并维持较高的目标血药浓度来降低急性移植物抗宿主病的发生率。
Am J Hematol. 2008 Mar;83(3):226-32. doi: 10.1002/ajh.21087.
8
Single-dose daily infusion of cyclosporine for prevention of Graft-versus-host disease after allogeneic bone marrow transplantation from HLA allele-matched, unrelated donors.每日单剂量输注环孢素预防来自HLA等位基因匹配的无关供体的异基因骨髓移植后的移植物抗宿主病。
Int J Hematol. 2006 Feb;83(2):159-63. doi: 10.1532/IJH97.05006.
9
The safety and efficacy of acute graft-versus-host disease prophylaxis with a higher target blood concentration of cyclosporine around 500 ng/mL.以环孢素更高的目标血药浓度(约 500ng/mL)预防急性移植物抗宿主病的安全性和有效性。
Clin Transplant. 2013 Sep-Oct;27(5):749-56. doi: 10.1111/ctr.12213. Epub 2013 Aug 20.
10
Pharmacokinetic monitoring of intravenous cyclosporine A in pediatric stem-cell transplant recipients. The trough level is not enough.儿科干细胞移植受者静脉注射环孢素A的药代动力学监测。谷浓度不够。
Pediatr Transplant. 2009 Jun;13(4):444-50. doi: 10.1111/j.1399-3046.2008.00968.x. Epub 2008 May 11.

引用本文的文献

1
Optimized cyclosporine starting dose may reduce risk of acute GvHD after allogeneic hematopoietic cell transplantation: a single-center cohort study.优化环孢素起始剂量可能降低异基因造血细胞移植后急性移植物抗宿主病的风险:一项单中心队列研究。
Bone Marrow Transplant. 2022 Apr;57(4):613-619. doi: 10.1038/s41409-022-01598-6. Epub 2022 Feb 8.
2
Pharmacokinetics, Pharmacodynamics and Pharmacogenomics of Immunosuppressants in Allogeneic Haematopoietic Cell Transplantation: Part I.异基因造血细胞移植中免疫抑制剂的药代动力学、药效学和药物基因组学:第一部分。
Clin Pharmacokinet. 2016 May;55(5):525-50. doi: 10.1007/s40262-015-0339-2.
3

本文引用的文献

1
Graft-versus-host disease.移植物抗宿主病
Lancet. 2009 May 2;373(9674):1550-61. doi: 10.1016/S0140-6736(09)60237-3. Epub 2009 Mar 11.
2
Decreased incidence of acute graft-versus-host disease by continuous infusion of cyclosporine with a higher target blood level.通过持续输注环孢素并维持较高的目标血药浓度来降低急性移植物抗宿主病的发生率。
Am J Hematol. 2008 Mar;83(3):226-32. doi: 10.1002/ajh.21087.
3
Risk factors for acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: retrospective analysis of 73 patients who received cyclosporin A.
Prophylactic and therapeutic treatment of graft-versus-host disease in Japan.
日本移植物抗宿主病的预防性和治疗性治疗。
Int J Hematol. 2015 May;101(5):467-86. doi: 10.1007/s12185-015-1784-2. Epub 2015 Apr 12.
4
Dose adjustment strategy of cyclosporine A in renal transplant patients: evaluation of anthropometric parameters for dose adjustment and C0 vs. C2 monitoring in Japan, 2001-2010.环孢素 A 在肾移植受者中的剂量调整策略:2001-2010 年日本对剂量调整的人体测量参数和 C0 与 C2 监测的评估。
Int J Med Sci. 2013 Sep 23;10(12):1665-73. doi: 10.7150/ijms.6727. eCollection 2013.
5
Estimation of Abbreviated Cyclosporine A Area under the Concentration-Time Curve in Allogenic Stem Cell Transplantation after Oral Administration.口服给药后同种异体干细胞移植中环孢素A简化浓度-时间曲线下面积的估算
J Transplant. 2012;2012:342701. doi: 10.1155/2012/342701. Epub 2011 Oct 26.
6
Methotrexate dose delivery is more important than ciclosporin level in graft-versus-host disease prophylaxis following T-replete reduced-intensity sibling allogeneic stem cell transplant.甲氨蝶呤剂量的给予比环孢素水平更重要,可预防 T 细胞充足的减低强度同胞异基因造血干细胞移植后移植物抗宿主病。
Int J Hematol. 2011 Sep;94(3):266-278. doi: 10.1007/s12185-011-0920-x. Epub 2011 Sep 7.
异基因造血干细胞移植后急性移植物抗宿主病的危险因素:对73例接受环孢素A治疗患者的回顾性分析
Bone Marrow Transplant. 2007 Nov;40(9):875-80. doi: 10.1038/sj.bmt.1705834. Epub 2007 Aug 27.
4
The clinical benefits of cyclosporine C2-level monitoring: a systematic review.环孢素C2水平监测的临床益处:一项系统评价。
Transplantation. 2007 Jun 27;83(12):1525-35. doi: 10.1097/01.tp.0000268306.41196.2c.
5
Cyclosporine short infusion and C2 monitoring in haematopoietic stem cell transplant recipients.造血干细胞移植受者的环孢素短期输注及C2监测
Bone Marrow Transplant. 2006 Oct;38(7):521-5. doi: 10.1038/sj.bmt.1705481.
6
Effect of blood cyclosporine concentration on the outcome of hematopoietic stem cell transplantation from an HLA-matched sibling donor.血中环孢素浓度对 HLA 配型相合同胞供者造血干细胞移植结局的影响。
Am J Hematol. 2006 Nov;81(11):838-44. doi: 10.1002/ajh.20710.
7
Optimizing the use of cyclosporin in allogeneic stem cell transplantation.优化环孢素在异基因干细胞移植中的应用
Bone Marrow Transplant. 2006 Aug;38(3):169-74. doi: 10.1038/sj.bmt.1705404. Epub 2006 Jun 5.
8
Single-dose daily infusion of cyclosporine for prevention of Graft-versus-host disease after allogeneic bone marrow transplantation from HLA allele-matched, unrelated donors.每日单剂量输注环孢素预防来自HLA等位基因匹配的无关供体的异基因骨髓移植后的移植物抗宿主病。
Int J Hematol. 2006 Feb;83(2):159-63. doi: 10.1532/IJH97.05006.
9
Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients.活体供肝移植患者中他克莫司和环孢素的药效学分析
Clin Pharmacol Ther. 2005 Aug;78(2):168-81. doi: 10.1016/j.clpt.2005.04.008.
10
High-dose cytosine arabinoside and etoposide with total body irradiation as a preparatory regimen for allogeneic hematopoietic stem-cell transplantation in patients with acute lymphoblastic leukemia.大剂量阿糖胞苷和依托泊苷联合全身照射作为急性淋巴细胞白血病患者异基因造血干细胞移植的预处理方案。
Bone Marrow Transplant. 2004 Aug;34(4):299-303. doi: 10.1038/sj.bmt.1704575.